Milking the cash cow: Pfizer plans to sell mRNA COVID-19 vaccine at 10,000% markup in 2023
Pharmaceutical giant Pfizer plans to sell its mRNA vaccine for the Wuhan coronavirus (COVID-19) at a 10,000 percent markup in 2023. A report by Quartz elaborated on the vaccine maker’s plan to jack up prices of its experimental injection. Initially, the first 100 million doses of BNT162b2 were …
Read More